Actionnariat et activité des initiés pour Nautilus Biotechnolgy, Inc. (NAUT): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.97 |
| Capitalisation | $124M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-18 | Posard Matthew L. | A-Award | 45,000 | $103K |
| 2026-06-18 | NAZEM FARZAD | A-Award | 45,000 | $103K |
| 2026-06-18 | Akinsanya Karen | A-Award | 45,000 | $103K |
| 2026-06-18 | McIlwain Matthew S | A-Award | 45,000 | $103K |
| 2026-06-18 | Epperly Melissa B, | A-Award | 45,000 | $103K |
| 2026-06-02 | AH Equity Partners Bio II, L.L.C. | S-Sale | 4,615,974 | $10.8M |
| 2026-06-02 | AH Equity Partners Bio II, L.L.C. | S-Sale | 384,026 | $902K |
| 2026-03-04 | Patel Sujal M | P-Purchase | 25,000 | $65K |
| 2026-03-02 | Mowry Anna | A-Award | 160,000 | $371K |
| 2026-03-02 | Mallick Parag | A-Award | 280,000 | $650K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $1.2M | $595000 | $36.6M | $185.6M | $114.5M | $19.4M | $27.6M | $12.4M |
| Placements à Court Terme | $144.49B | $16.1M | $40.1M | $160.1M | $69.9M | $154.0M | $102.2M | $91.0M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $1.3M | $17.0M | $77.7M | $349.2M | $187.2M | $176.8M | $132.8M | $106.0M |
| Immobilisations Corporelles | 0 | $1.1M | $6.2M | $31.9M | $32.6M | $36.9M | $32.3M | $31.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $145.8M | $18.5M | $85.0M | $398.4M | $350.1M | $305.6M | $242.7M | $191.1M |
| Dettes Fournisseurs | 0 | $289000 | $470000 | $1.7M | $1.3M | $1.6M | $987000 | $943000 |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $5000 | $490000 | $3.0M | $5.8M | $6.8M | $9.1M | $7.6M | $8.0M |
| Dette à Long Terme | $5.0M | $275.0M | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $140.8M | $490000 | $114.7M | $34.9M | $35.1M | $40.2M | $34.0M | $34.1M |
| Réserves | $626600 | -$14.7M | -$30.3M | -$80.6M | -$138.6M | -$202.2M | -$273.0M | -$332.0M |
| Capitaux Propres | $5.0M | $18.1M | -$29.7M | $363.6M | $314.9M | $265.4M | $208.7M | $157.0M |
| Dette Totale | $5.0M | $275.0M | $4.8M | $30.0M | $30.3M | $34.6M | $30.5M | $30.0M |
| Dette Nette | -$144.48B | $258.3M | -$72.0M | -$315.7M | -$154.1M | -$138.8M | -$99.4M | -$73.4M |
| Fonds de Roulement | $1.3M | $16.5M | $74.6M | $343.4M | $180.4M | $167.7M | $125.2M | $98.0M |
Santé financière
| Dette / Capitaux propres | 0.21 |
| Ratio de liquidité | 10.14 |
Rentabilité
| Rentabilité des capitaux propres | -37.58% |
| Rentabilité du capital investi | -39.50% |
| Rentabilité des actifs | -34.55% |
| Marge brute | -919.47% |
| Marge opérationnelle | -33043.68% |
| Marge nette | -29747.89% |
Entreprises liées: ARCT · ASMB · ENTA · FHTX · HUMA · IMRX · PYXS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de NAUT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions